These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24330971)

  • 1. [Phagotherapy: a nightmare for bacteria, a dream for physicians?].
    Debarbieux L; Saussereau E; Maura D
    Biol Aujourdhui; 2013; 207(3):181-90. PubMed ID: 24330971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections.
    Soothill J
    Expert Rev Anti Infect Ther; 2013 Sep; 11(9):909-15. PubMed ID: 24053272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental phage therapy in the beginning of the 21st century].
    Debarbieux L
    Med Mal Infect; 2008 Aug; 38(8):421-5. PubMed ID: 18692973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages as twenty-first century antibacterial tools for food and medicine.
    Maura D; Debarbieux L
    Appl Microbiol Biotechnol; 2011 May; 90(3):851-9. PubMed ID: 21491205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections.
    Debarbieux L; Leduc D; Maura D; Morello E; Criscuolo A; Grossi O; Balloy V; Touqui L
    J Infect Dis; 2010 Apr; 201(7):1096-104. PubMed ID: 20196657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of bacteriophage preparations on migration of HL-60 leukemia cells in vitro.
    Kurzepa-Skaradzinska A; Skaradzinski G; Weber-Dabrowska B; Zaczek M; Maj T; Slawek A; Switalska M; Maciejewska M; Wietrzyk J; Rymowicz W; Gorski A
    Anticancer Res; 2013 Apr; 33(4):1569-74. PubMed ID: 23564799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
    Abd El-Aziz AM; Elgaml A; Ali YM
    J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental infections of mice with bacteriophages.
    Soothill JS
    J Med Microbiol; 1992 Oct; 37(4):258-61. PubMed ID: 1404324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages as an alternative strategy for fighting biofilm development.
    Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A
    Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases.
    Slopek S; Durlakowa I; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):317-35. PubMed ID: 6395825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophages as potential treatment option for antibiotic resistant bacteria.
    Bragg R; van der Westhuizen W; Lee JY; Coetsee E; Boucher C
    Adv Exp Med Biol; 2014; 807():97-110. PubMed ID: 24619620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on bacteriophage penetration in patients subjected to phage therapy.
    Weber-Dabrowska B; Dabrowski M; Slopek S
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):563-8. PubMed ID: 3332066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?
    Brüssow H
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.